While drugmaker Dr Reddy's Laboratories' Q3 earnings were slightly above the Street's estimates, the highlight of the show was declining revenue contribution from Revlimid, which also weighed on ...

Shares of Dr Reddy's Laboratories tumbled as much as 7 per cent during the trading session on Friday after the leading pharmaceuticals player reported a muted set of numbers in the December 2024 ...

Pharma major Dr. Reddy’s Laboratories on Thursday announced ... first how we can have a robust product portfolio of our in house. We are also looking at emerging markets. We continue to have ...

Motilal Oswal Jan 24 2025 01:19 PM Reduce Dr. Reddy's Laboratories; target of Rs 1335: Prabhudas Lilladher Jan 24 2025 01:19 PM ...

Steve Pfost/Newsday RM via Getty The man also shared that he and his parents made a verbal agreement that he would ultimately get a larger share of the house as compared to his sister when his ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

While the 31-year-old Bachelor follows his heart, he will have the support of his parents, who will eventually meet two of the contestants. In an interview with Us Weekly, he shared ...

Senior leader V Vijay Sai Reddy, who resigned from the YSR Congress party and his Rajya Sabha membership, made it clear that he was quitting politics not to wriggle out of the cases against him. “I am ...

followed by a series of raids that were conducted at the personal properties of the production house owners , Naveen Yerni and Ravi Shankar. Going by the silence on the matter, many speculated ...

I believe age and experience have made us better and wiser parents. Since we had her ... her own physical-therapy practice at home. Being a house dad for the first 18 months of my daughter's ...

Dr Reddy's Laboratories Stock Price: Dr Reddy's shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE). Listen to Story ...

Dr Reddy's Laboratories (DRL), plans to launch 15 to 20 products each year to maintain its market presence, CEO Erez Israeli said. Despite challenges with certain products, Israeli believes that the ...